Table 3.

Multivariable odds ratios and 95% confidence limits for clinical variables associated with control of BP and LDL-C and non-HDL cholesterol (NCEP III Goals) in NHANES 1988–2010 combined (Figure 3).

Descriptor	Control of LDL			Control of LDL and Non-HDL			Control of Htn and LDL			Control of Htn, LDL and Non-HDL
	Odds	LCL	UCL	Odds	LCL	UCL	Odds	LCL	UCL	Odds	LCL	UCL
Age/10 years	0.78	0.71	0.87	0.75	0.67	0.83	0.75	0.67	0.83	0.77	0.69	0.88
Gender
Male	0.71	0.58	0.86	0.72	0.59	0.89	0.86	0.68	1.09	0.83	0.65	1.07
Race
Black	0.69	0.52	0.91	0.57	0.43	0.75	0.48	0.36	0.64	0.59	0.44	0.80
Hispanic	0.75	0.56	1.00	0.78	0.58	1.06	0.60	0.43	0.84	0.62	0.43	0.90
Other	0.94	0.52	1.70	1.48	0.78	2.83	1.24	0.68	2.26	1.69	0.88	3.25
BMI
<25	1.07	0.76	1.51	1.11	0.76	1.63	1.25	0.86	1.80	1.08	0.72	1.64
≥ 30	1.23	0.90	1.68	1.35	0.97	1.88	1.40	0.94	2.06	1.17	0.78	1.78
Visits /year
(2–3 vs 0–1)	1.09	0.82	1.46	1.21	0.85	1.71	1.89	1.25	2.87	1.96	1.23	3.11
(≥ 4 vs 0–1)	1.17	0.87	1.58	1.22	0.89	1.67	1.90	1.30	2.77	1.86	1.23	2.80
Uninsured	1.23	0.82	1.83	1.50	1.00	2.26	1.20	0.77	1.88	1.35	0.81	2.25
Blood Pressure
SBP /10mm Hg	0.89	0.82	0.96	0.88	0.79	0.97	x	x	x	x	x	x
DBP /10mm Hg	0.93	0.87	1.00	0.90	0.84	0.98	x	x	x	x	x	x
BP <140/<90	0.96	0.74	1.24	0.81	0.57	1.14	x	x	x	x	x	x
BP meds	1.02	0.78	1.33	1.01	0.74	1.37	3.01	2.38	3.82	3.32	2.45	4.50
Lipids
HDL /(10mg/dl)	0.88	0.81	0.94	x	x	x	x	x	x	x	x	x
Triglycerid es (100mg/dl)	1.11	0.90	1.22	0.50	0.40	0.55	x	x	x	x	x	x
Non-statin	3.07	1.83	5.14	3.85	2.55	5.79	2.37	1.33	4.24	2.67	1.52	4.68
Statin	18.0	13.9	23.2	21.0	16.3	27.0	7.94	6.25	10.1	10.7	8.05	14.3
Risk Factors
Smoke	0.83	0.64	1.08	0.88	0.63	1.22	1.19	0.89	1.58	1.14	0.80	1.63
CKD	1.23	0.92	1.64	1.28	0.97	1.68	0.99	0.73	1.35	0.94	0.68	1.29
CVD	0.26	0.20	0.34	0.26	0.19	0.35	0.45	0.35	0.57	0.44	0.34	0.56
DM	0.49	0.39	0.61	0.44	0.35	0.56	0.65	0.50	0.83	0.54	0.42	0.70